ORIGINALMINE
CG Bio Co., Ltd.
Application Filed: 2021-07-12
Trademark Application Details
NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
| Research |
OneLook
Acronym Finder
|
| Serial Number | 79318054 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
Timeline
| 2021-07-12 | Application Filed |
| 2021-08-12 | Location: INITIAL REVIEW/SERIALIZATION BRANCH(MAILROOM) |
| 2021-08-12 | Status: Live/Pending |
| 2021-08-17 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  CG Bio Co., Ltd. |
| Address | 3F, 211, Itaewon-ro, Yongsan-gu Seoul KR |
| Legal Entity Type | Corporation |
| Legal Entity State | KR |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 005,006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | Arterial grafts; implants comprising living tissue; surgical implants comprising living tissue; processed human donor skin for the replacement of soft tissue; live organs and tissues for surgical purpose; surgical implants (living tissues); transplants (living tissues); human allograft tissue; implants for guided tissue regeneration; implantable materials for use in guided tissue regeneration; surgical implants grown from stem cells (living tissues); surgical implants grown from stem cells; skin grafts; vascular grafts (living tissue); filled syringes for medical purposes (containing pharmaceuticals); pre-filled syringes for medical purposes; medicinal infusions; pharmaceuticals; medicines for human purposes; injectable dermal fillers; implantable medicines |
| GS0051 | Arterial grafts; implants comprising living tissue; surgical implants comprising living tissue; processed human donor skin for the replacement of soft tissue; live organs and tissues being surgical implants comprised of living tissue for surgical purpose; surgical implants comprised of living tissues; living tissue transplants in the nature of implants comprising living tissue; human allograft tissue; implants for guided tissue regeneration, namely, implants comprising living tissue; implantable materials for use in guided tissue regeneration in the nature of implants comprising living tissue; surgical implants comprised of living tissues, grown from stem cells; skin grafts; living tissue vascular grafts; syringes sold filled with hyaluronic acid for medical purposes; pre-filled syringes of hyaluronic acid for medical purposes; medicinal infusions for treating soft tissue infections of the skin; medicinal infusions, namely, medicated skin care preparations for treating the lips and face; medicinal infusions for breast augmentation and penis enlargement; medicinal infusions for implanting artificial bones; medicinal infusions with demineralized bone matrix (DBM), biocompatible ceramic material and poloxamers derived from human tissue, for accelerating bone formation; pharmaceutical preparations for the treatment of wounds; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for treating epidermal problems; pharmaceutical preparations for treating damaged skin and tissue; medicines for human purposes, namely, medicated skin care preparations for treating foot ulcers, dry and itchy skin, postoperative wounds and burned skin; injectable dermal fillers; implantable medicines being surgical implants comprised of living tissues |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| SN ASSIGNED FOR SECT 66A APPL FROM IB | 2021-08-12 | 1 REPR M: |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2021-08-17 | 2 NWOS I:Incoming Correspondence |
| APPLICATION FILING RECEIPT MAILED | 2021-08-21 | 3 MAFR O:Outgoing Correspondence |
| ASSIGNED TO EXAMINER | 2022-03-30 | 4 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2022-04-12 | 5 CNRT R:Renewal |
| NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | 2022-04-13 | 6 RFCR E:E-Mail |
| REFUSAL PROCESSED BY MPU | 2022-04-18 | 7 RFRR P: |
| NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | 2022-04-18 | 8 RFCS P: |
| REFUSAL PROCESSED BY IB | 2022-05-10 | 9 RFNT P: |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2022-07-07 | 10 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2022-07-07 | 11 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2022-07-08 | 12 TEME I:Incoming Correspondence |
| FINAL REFUSAL WRITTEN | 2022-08-11 | 13 CNFR R:Renewal |
| FINAL REFUSAL E-MAILED | 2022-08-11 | 14 GNFR O:Outgoing Correspondence |
| NOTIFICATION OF FINAL REFUSAL EMAILED | 2022-08-11 | 15 GNFN O:Outgoing Correspondence |
| TEAS REQUEST FOR RECONSIDERATION RECEIVED | 2022-11-23 | 16 ERFR I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2022-11-23 | 17 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2022-11-24 | 18 TEME I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2022-12-06 | 19 CNSA O:Outgoing Correspondence |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2022-12-21 | 20 NONP E:E-Mail |
| NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | 2023-01-04 | 21 OP2R P: |
| NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | 2023-01-04 | 22 OPNS P: |
| PUBLISHED FOR OPPOSITION | 2023-01-10 | 23 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2023-01-10 | 24 NPUB E:E-Mail |
| NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | 2023-01-18 | 25 OPNR P: |
| NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | 2023-01-18 | 26 OPNS P: |
| NOTIFICATION PROCESSED BY IB | 2023-01-24 | 27 GPNX P: |
| NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | 2023-02-06 | 28 OPNX P: |
| REGISTERED-PRINCIPAL REGISTER | 2023-03-28 | 29 R.PR A:Allowance for Publication |
| NOTICE OF REGISTRATION CONFIRMATION EMAILED | 2023-03-28 | 30 NRCC E:E-Mail |
| FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | 2023-06-28 | 31 FICR P: |
| FINAL DISPOSITION PROCESSED | 2023-07-13 | 32 FIMP P: |
| FINAL DISPOSITION NOTICE SENT TO IB | 2023-07-13 | 33 FICS P: |
| FINAL DECISION TRANSACTION PROCESSED BY IB | 2023-08-07 | 34 FINO P: |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 